 MANAGEMENT TEAM
|
Roger A. Hubbard, PhD
Founder, President, Chief Executive Officer
Dr. Roger Hubbard provides scientific and executive leadership to Geneuity and its parent company, Molecular Pathology Laboratory Network, Inc. (MPLN).
In 1989, Dr. Hubbard founded MPLN after completing doctoral studies in biochemistry and molecular biology at the Medical University of South Carolina in Charleston and subsequent training in the Department of Microbiology and Immunology at the University of Arizona Health Sciences Center in Tucson. He holds the academic rank of adjunct associate professor in the Department of Pathology at the University of Tennessee Medical Center in Knoxville and holds the High-complexity Clinical Laboratory Director certification from the American Board of Bioanalysis.
Dr. Hubbard is a laboratory inspector within the Laboratory Accreditation Program of the College of American Pathologists. Dr. Hubbard is a clinical scientist member of the American Society of Clinical Pathologists and a charter member of the Clinical Cytometry Society. He has written numerous publications in the areas of clinical flow cytometry, molecular immunology, infectious disease diagnostic testing and molecular oncology.
L. Ranee Taylor, PhD
Director, Business Development
Dr. Ranee Taylor is responsible for business development of Geneuity’s clinical trials and research services. Dr. Taylor has more than 14 years of experience in molecular biology and research development. Prior to joining Geneuity, Dr. Taylor served as a research associate in the Department of Medicine at The University of Iowa and as a consultant for Oak Ridge National Laboratory.
Dr. Taylor received her doctorate in Human and Molecular Genetics from Baylor College of Medicine in Houston and completed post-doctoral training in molecular immunology at The University of Iowa Hospitals and Clinics. Dr. Taylor is a cum laude graduate of Baylor University, with a bachelor’s degree in Biology. Dr. Taylor has authored a number of publications in the areas of molecular genetics and immunology and received several National Research Service Awards. She is a member of the East Tennessee Economic Council and a past board member of the Knoxville Academy of Medicine Alliance.
|
Neil B. Quigley, PhD, HCLD(ABB)
Vice President, Geneuity
Dr. Neil Quigley directs all the research services of Geneuity and is responsible for new test development and clinical trials. Dr. Quigley has more than 20 years of molecular genetics research experience, is board certified in molecular diagnostics by the American Board of Bioanalysis and licensed by the State of Tennessee as a clinical laboratory director in molecular diagnostics, and is a member of the American Society for Microbiology and the Association for Molecular Pathology.
Before joining Geneuity’s parent company, Dr. Quigley was a research assistant professor of microbiology at the University of Tennessee in Knoxville and director of the UT Molecular Biology Resource Facility. Dr. Quigley received his doctoral degree from the University of Auckland in New Zealand and completed post-doctoral training in Australia and at Washington State University.
Donald Henley
Manager, Clinical Research Services Laboratory
Donald Henley manages Geneuity’s clinical research services laboratory. He has extensive clinical research experience, including six years of cancer genetics research at the Oak Ridge National Laboratory and several years in cellular signal transduction research in breast cancer cell models at the University of Tennessee Medical Center in Knoxville. Henley has developed and clinically validated several molecular diagnostic assays specifically for use in clinical trials. Henley earned his bachelor and master of science degrees at the University of Tennessee, Knoxville.
|
|